GROWTH FACTORS IN THE ADULT AND AGING BRAIN
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
批准号:
6509538
负责人:
MARIANN M BLUM
金额:
$26.03万
依托单位国家:
美国
项目类别:
财政年份:
1992
资助国家:
美国
项目状态:
已结题
起止时间:
1992-05-01 至 2005-04-30
关键词:
DNA footprinting Parkinson's disease age difference aging astrocytes cytokine receptors disease /disorder model dopamine embryo /fetus tissue transplantation gene expression glial fibrillary acidic protein interleukin 1 laboratory mouse mesencephalon methylphenyltetrahydropyridine nervous system regeneration neural degeneration neural plasticity neurotrophic factors substantia nigra tissue /cell culture
中文摘要
帕金森病是一种影响老年人的进行性神经退行性疾病,其特征是黑质纹状体区域神经元的神经变性。我们实验室的研究主要集中在确定多巴胺神经元存活和可塑性的重要因素,这些因素可以保护它们免于退化,或者多巴胺神经元存活和可塑性的重要因素,这些因素可以保护它们免于退化或增强代偿反应。在MPTP诱导的毒性反应中,中脑多巴胺能神经元表现出一定的再生能力,因为用毒素治疗的年轻动物能够自发恢复。然而,在正常的衰老过程中,多巴胺能神经元的这种再生能力大大降低。在MPTP诱导的年轻小鼠黑质多巴胺神经元退化中,我们观察到IL-1 α的强烈诱导持续了近两周,并与腹侧被盖多巴胺神经元的侧枝萌发有关。相反,对于中年小鼠,我们既没有检测到IL-1 α的诱导,也没有检测到侧枝发芽。为了确定这种IL-1 α的诱导是否对病变诱导发芽的发生是必要的,我们建议在高亲和力IL-1 α受体被基因消融的小鼠中进行进一步的实验。在进一步的研究中,我们获得的证据表明,中年小鼠的细胞外基质可能发生变化,这也可能导致可塑性降低。因此,我们建议进一步研究是否IL-1的异位表达,通过逆转录病毒感染中年小鼠的祖细胞,可以刺激多巴胺神经元的代偿发芽。此外,为了直接解决细胞外环境是否在降低多巴胺能神经元侧枝发芽的能力中起作用,我们建议将胎儿多巴胺能神经元移植到年轻和中年小鼠中,并比较纤维生长的程度。在中枢神经系统的特定区域,神经元死亡,并不断被新发育的神经元所取代。最近人们认识到,神经干细胞比以前认为的更广泛地分散,并且可以在脑损伤的反应中诱导增殖。我们有初步的数据显示,在MPTP的反应中,新增殖的细胞可以在黑质中发现,这些细胞可以具有未承诺的表型。经过较长时间的标记后,我们的数据表明这些细胞可能最终分化为多巴胺神经元。因此,我们建议确定新的多巴胺神经元是在损伤反应中产生的,还是可以通过异位表达细胞因子来刺激分化,这些细胞因子能够调节神经元的生长。
英文摘要
Parkinson's disease is a progressive neurodegenerative disorder affecting the elderly, characterized by neurodegeneration of nigrostriatal domain neurons. Studies in our laboratory have been focused on identifying factors that are important for the survival and plasticity of dopamine neurons, which could protect them from degeneration or that are important for the survival and plasticity of dopamine neurons, which could protect them from degeneration or enhance compensatory responses. In response to MPTP induced toxicity, midbrain dopaminergic neurons exhibit some regenerative capacity, for young animals treated with the toxin are able to spontaneously recover. However, in the process of normal aging, this regenerative capacity of dopaminergic neurons becomes greatly reduced. We observed in response to MPTP induced degeneration of substantia nigra dopamine neurons in young mice, that there is a robust induction of IL-1 alpha which lasts for nearly two weeks and is associated with collateral sprouting of the ventral tegmental dopamine neurons. In contrast, to middle-aged mice we detected neither an induction of IL-1 alpha or collateral sprouting. To determine whether this induction of IL-1 alpha is necessary for lesion-induced sprouting to occur we are proposing to perform further experiments in mice in which the high affinity IL-1 alpha receptor has been genetically ablated. In further studies we obtained evidence that there may be changes in the extracellular matrix in middle-aged mice that may also contribute to reduced plasticity. Thus, we propose further studies to determine whether ectopic expression of IL-1, by retroviral infection of progenitor cells in middle-aged mice, can stimulate compensatory sprouting of dopamine neurons. In addition, to directly address whether the extracellular environment is play a role in reducing the ability of dopaminergic neurons to collateral sprout, we are proposing to graft fetal dopaminergic neurons into young and middle aged mice and compare the extent of fiber outgrowth. In specific regions of the CNS, neurons die and are being continuously replaced with newly developed neurons. It has recently become appreciated that neural stem cells are more widely dispersed than previously thought and can be induced to proliferate in response to brain injury. We have preliminary data showing that in response to MPTP, newly proliferated cells can be found in the substantia nigra which can have an un-committed phenotype. After longer periods of time after labeling our data suggests the possibility that these cells may eventually differentiate into dopamine neurons. Thus, we propose to establish whether new dopamine neurons are produced in response to injury or can be stimulated to differentiate by ectopically expressing cytokines, which are able to regulate neuronal.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ECM and the Differentiation/Plasticity of DA Neurons
-
批准号:6474940
-
项目类别:
-
资助金额:$27.71万
-
财政年份:2002
-
负责人:MARIANN M BLUM
-
依托单位:
PROTEOGLYCAN METABOLISM IN AGING AND DEMENTIA
-
批准号:2519985
-
项目类别:
-
资助金额:$18.89万
-
财政年份:1996
-
负责人:MARIANN M BLUM
-
依托单位:
PROTEOGLYCAN METABOLISM IN AGING AND DEMENTIA
-
批准号:2038255
-
项目类别:
-
资助金额:$18.05万
-
财政年份:1996
-
负责人:MARIANN M BLUM
-
依托单位:
PROTEOGLYCAN METABOLISM IN AGING AND DEMENTIA
-
批准号:2771960
-
项目类别:
-
资助金额:$19.65万
-
财政年份:1996
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:3120230
-
项目类别:
-
资助金额:$1.8万
-
财政年份:1994
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:2050265
-
项目类别:
-
资助金额:$20.23万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:2413313
-
项目类别:
-
资助金额:$21.25万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:3120229
-
项目类别:
-
资助金额:$10.73万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:2050262
-
项目类别:
-
资助金额:$18.9万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:2909628
-
项目类别:
-
资助金额:$23.0万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:6053734
-
项目类别:
-
资助金额:$28.71万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:2699756
-
项目类别:
-
资助金额:$22.12万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:3120231
-
项目类别:
-
资助金额:$14.4万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:2050263
-
项目类别:
-
资助金额:$18.93万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
GROWTH FACTORS IN THE ADULT AND AGING BRAIN
-
批准号:6371739
-
项目类别:
-
资助金额:$25.28万
-
财政年份:1992
-
负责人:MARIANN M BLUM
-
依托单位:
海外基金